References
- Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015;86(9):1036–1043.
- Benson MD, Dasgupta NR, Rao R. Diagnosis and screening of patients with hereditary transthyretin amyloidosis (hATTR): current strategies and guidelines. Ther Clin Risk Manag. 2020;16:749–758.
- Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75(3):408–427.
- Adams D, Ando Y, Melo Beirão J, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2021;268(6):2109–2122.
- Lemos C, Coelho T, Alves-Ferreira M, et al. Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M. J Neurol Neurosurg Psychiatry. 2014;85(3):326–330.
- Nakamura M, Yamashita T, Ueda M, et al. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology. 2005;65(7):1051–1056.
- Maia LF, Magalhães R, Freitas J, et al. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. J Neurol Neurosurg Psychiatry. 2015;86(2):159–167.
- Salvi F, Pastorelli F, Plasmati R, et al. Brain microbleeds 12 years after orthotopic liver transplantation in Val30Met amyloidosis. J Stroke Cerebrovasc Dis. 2015;24(6):e149-151–e151.
- Sekijima Y, Yazaki M, Oguchi Z, et al. Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis. Neurology. 2016;87(8):773–781.
- Franco A, Bentes C, Carvalho M, et al. Epileptic seizures as a presentation of central nervous system involvement in TTR Val30Met-FAP. J Neurol. 2016;263(11):2336–2338.
- Freitas Castro V, Nascimento Alves P, Franco AC, et al. Cognitive impairment in liver transplanted patients with transthyretin-related hereditary amyloid polyneuropathy. Amyloid. 2017;24(2):110–114.
- Martins da Silva A, Cavaco S, Fernandes J, et al. Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis. J Neurol. 2018;265(2):299–307.
- Nakajima M, Takeuchi Y, Nagao Y, et al. Comparison of clinical features in transient focal neurological episodes between hereditary transthyretin type and Abeta type cerebral amyloid angiopathy. Amyloid. 2019;26(sup1):81–82.
- Dardiotis E, Andreou S, Aloizou AM, et al. The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients. Neurol Sci. 2020;41(5):1163–1170.
- Suhr OB, Svendsen IH, Ohlsson PI, et al. Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis. Amyloid. 1999;6(3):187–191.
- Li X, Buxbaum JN. Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer’s disease? Mol Neurodegener. 2011;6:79.
- Durmuş H, Çakar A, Demirci H, et al. An exploratory study of cognitive involvement in hereditary transthyretin amyloidosis. Acta Neurol Scand. 2021;144(6):640–646.
- Hamasaki H, Shijo M, Nakamura A, et al. Concurrent cardiac transthyretin and brain β amyloid accumulation among the older adults: the Hisayama study. Brain Pathol. 2022;32(1):e13014.
- Wange N, Anan I, Ericzon BG, et al. Atrial fibrillation and central nervous complications in liver transplanted hereditary transthyretin amyloidosis patients. Transplantation. 2018;102(2):e59–e66.